Dr. Sirgo brings over 35 years of pharmaceutical experience to Aruna Bio from drug development through global product commercialization. Most recently, Dr. Sirgo served as President and CEO of BioDelivery Sciences International (BDSI:Nasdaq), a specialty pharmaceutical company focused in CNS/pain. While leading BDSI, Dr. Sirgo was successful in raising nearly $600 million in capital through partnerships and financings to support the development, FDA approval and commercial launch of three products utilizing the company’s proprietary drug delivery technology.
Dr. Sirgo serves on the Board of Directors for a number of pharmaceutical and medical diagnostic companies including BioDelivery Sciences, BioMerica, Inc (BMRX:Nasdaq), 9 Meters Biopharma (NMTR) and formerly Salix Pharmaceuticals (SLXP:Nasdaq). He earned a Bachelor of Science in Pharmacy from The Ohio State University and a Doctor of Pharmacy from the Philadelphia College of Pharmacy and Sciences.
Dr. Sirgo serves on the Board of Directors for a number of pharmaceutical and medical diagnostic companies including BioDelivery Sciences, BioMerica, Inc (BMRX:Nasdaq), 9 Meters Biopharma (NMTR) and formerly Salix Pharmaceuticals (SLXP:Nasdaq). He earned a Bachelor of Science in Pharmacy from The Ohio State University and a Doctor of Pharmacy from the Philadelphia College of Pharmacy and Sciences.
Speaking In
[Available On-Demand]
Aruna Bio, Inc. is a privately funded biotechnology company focused on the development of neural…